Lymphocytic duodenosis and the spectrum of celiac disease

Jennifer Vande Voort, Joseph A Murray, Brian D. Lahr, Carol T. Van Dyke, Cynthia M. Kroning, S. Breanndan Moore, Tsung Teh Wu

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

OBJECTIVES: Celiac disease (CD) is a chronic inflammatory disease of the small bowel that is characterized by increased intraepithelial lymphocytes (IELs) and villous atrophy of the mucosa. It is unclear how often intraepithelial lymphocytosis in the absence of atrophy is a manifestation of gluten sensitive enteropathy. The objective of this study was to identify factors that discriminate patients with CD from those with lymphocytic duodenosis (LD, intraepithelial lymphocytosis without villous atrophy). We compared Class 2 HLA type, presenting symptoms, and serology in patients with LD and CD. METHODS: Retrospective review of 124 systematically assessed patients with LD compared with 454 CD patients with villous atrophy. All patients had duodenal biopsies and Class 2 HLA typing performed. HLA type, symptoms, serology pattern, and response to a gluten-free diet were analyzed using univariate logistic regression modeling, adjusted for age and gender. RESULTS: Half of the (63 (51)) LD patients lack the Class 2 HLA genotypes encoding DQ2 or DQ8 whereas only 11 (2) CD patients had neither DQ2 nor DQ8, P<0.001. The genes encoding DQ2 were much more prevalent in CD (91) than that in LD (37, P<0.001), however, the rate of carriage of DQ8 did not differ between the two groups (15 vs. 15, P0.9). Although diarrhea and weight loss were equally frequent in LD and CD patients, LD patients were less likely to be associated with anemia (P0.007), malaise (P0.006), skin disorder (P0.007), or a family history of CD (P<0.001). The LD subjects were much less likely to have tissue transglutaminase or endomysial antibodies than were CD subjects (12 or 0 vs. 87 and 87; P<0.001, respectively). CONCLUSIONS: The LD cohort differs significantly in terms of HLA type, serology, and clinical features, suggesting that the majority of patients with LD do not belong in the spectrum of CD.

Original languageEnglish (US)
Pages (from-to)142-148
Number of pages7
JournalAmerican Journal of Gastroenterology
Volume104
Issue number1
DOIs
StatePublished - Jan 2009

Fingerprint

Celiac Disease
Atrophy
Serology
Lymphocytosis
Gluten-Free Diet
Histocompatibility Testing
Anemia
Weight Loss
Diarrhea
Mucous Membrane
Chronic Disease
Logistic Models
Genotype
Lymphocytes
Biopsy
Skin

ASJC Scopus subject areas

  • Gastroenterology
  • Medicine(all)

Cite this

Lymphocytic duodenosis and the spectrum of celiac disease. / Vande Voort, Jennifer; Murray, Joseph A; Lahr, Brian D.; Van Dyke, Carol T.; Kroning, Cynthia M.; Moore, S. Breanndan; Wu, Tsung Teh.

In: American Journal of Gastroenterology, Vol. 104, No. 1, 01.2009, p. 142-148.

Research output: Contribution to journalArticle

Vande Voort, Jennifer ; Murray, Joseph A ; Lahr, Brian D. ; Van Dyke, Carol T. ; Kroning, Cynthia M. ; Moore, S. Breanndan ; Wu, Tsung Teh. / Lymphocytic duodenosis and the spectrum of celiac disease. In: American Journal of Gastroenterology. 2009 ; Vol. 104, No. 1. pp. 142-148.
@article{ce2aa8a9a75a4209aa2d26380e05d1be,
title = "Lymphocytic duodenosis and the spectrum of celiac disease",
abstract = "OBJECTIVES: Celiac disease (CD) is a chronic inflammatory disease of the small bowel that is characterized by increased intraepithelial lymphocytes (IELs) and villous atrophy of the mucosa. It is unclear how often intraepithelial lymphocytosis in the absence of atrophy is a manifestation of gluten sensitive enteropathy. The objective of this study was to identify factors that discriminate patients with CD from those with lymphocytic duodenosis (LD, intraepithelial lymphocytosis without villous atrophy). We compared Class 2 HLA type, presenting symptoms, and serology in patients with LD and CD. METHODS: Retrospective review of 124 systematically assessed patients with LD compared with 454 CD patients with villous atrophy. All patients had duodenal biopsies and Class 2 HLA typing performed. HLA type, symptoms, serology pattern, and response to a gluten-free diet were analyzed using univariate logistic regression modeling, adjusted for age and gender. RESULTS: Half of the (63 (51)) LD patients lack the Class 2 HLA genotypes encoding DQ2 or DQ8 whereas only 11 (2) CD patients had neither DQ2 nor DQ8, P<0.001. The genes encoding DQ2 were much more prevalent in CD (91) than that in LD (37, P<0.001), however, the rate of carriage of DQ8 did not differ between the two groups (15 vs. 15, P0.9). Although diarrhea and weight loss were equally frequent in LD and CD patients, LD patients were less likely to be associated with anemia (P0.007), malaise (P0.006), skin disorder (P0.007), or a family history of CD (P<0.001). The LD subjects were much less likely to have tissue transglutaminase or endomysial antibodies than were CD subjects (12 or 0 vs. 87 and 87; P<0.001, respectively). CONCLUSIONS: The LD cohort differs significantly in terms of HLA type, serology, and clinical features, suggesting that the majority of patients with LD do not belong in the spectrum of CD.",
author = "{Vande Voort}, Jennifer and Murray, {Joseph A} and Lahr, {Brian D.} and {Van Dyke}, {Carol T.} and Kroning, {Cynthia M.} and Moore, {S. Breanndan} and Wu, {Tsung Teh}",
year = "2009",
month = "1",
doi = "10.1038/ajg.2008.7",
language = "English (US)",
volume = "104",
pages = "142--148",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Lymphocytic duodenosis and the spectrum of celiac disease

AU - Vande Voort, Jennifer

AU - Murray, Joseph A

AU - Lahr, Brian D.

AU - Van Dyke, Carol T.

AU - Kroning, Cynthia M.

AU - Moore, S. Breanndan

AU - Wu, Tsung Teh

PY - 2009/1

Y1 - 2009/1

N2 - OBJECTIVES: Celiac disease (CD) is a chronic inflammatory disease of the small bowel that is characterized by increased intraepithelial lymphocytes (IELs) and villous atrophy of the mucosa. It is unclear how often intraepithelial lymphocytosis in the absence of atrophy is a manifestation of gluten sensitive enteropathy. The objective of this study was to identify factors that discriminate patients with CD from those with lymphocytic duodenosis (LD, intraepithelial lymphocytosis without villous atrophy). We compared Class 2 HLA type, presenting symptoms, and serology in patients with LD and CD. METHODS: Retrospective review of 124 systematically assessed patients with LD compared with 454 CD patients with villous atrophy. All patients had duodenal biopsies and Class 2 HLA typing performed. HLA type, symptoms, serology pattern, and response to a gluten-free diet were analyzed using univariate logistic regression modeling, adjusted for age and gender. RESULTS: Half of the (63 (51)) LD patients lack the Class 2 HLA genotypes encoding DQ2 or DQ8 whereas only 11 (2) CD patients had neither DQ2 nor DQ8, P<0.001. The genes encoding DQ2 were much more prevalent in CD (91) than that in LD (37, P<0.001), however, the rate of carriage of DQ8 did not differ between the two groups (15 vs. 15, P0.9). Although diarrhea and weight loss were equally frequent in LD and CD patients, LD patients were less likely to be associated with anemia (P0.007), malaise (P0.006), skin disorder (P0.007), or a family history of CD (P<0.001). The LD subjects were much less likely to have tissue transglutaminase or endomysial antibodies than were CD subjects (12 or 0 vs. 87 and 87; P<0.001, respectively). CONCLUSIONS: The LD cohort differs significantly in terms of HLA type, serology, and clinical features, suggesting that the majority of patients with LD do not belong in the spectrum of CD.

AB - OBJECTIVES: Celiac disease (CD) is a chronic inflammatory disease of the small bowel that is characterized by increased intraepithelial lymphocytes (IELs) and villous atrophy of the mucosa. It is unclear how often intraepithelial lymphocytosis in the absence of atrophy is a manifestation of gluten sensitive enteropathy. The objective of this study was to identify factors that discriminate patients with CD from those with lymphocytic duodenosis (LD, intraepithelial lymphocytosis without villous atrophy). We compared Class 2 HLA type, presenting symptoms, and serology in patients with LD and CD. METHODS: Retrospective review of 124 systematically assessed patients with LD compared with 454 CD patients with villous atrophy. All patients had duodenal biopsies and Class 2 HLA typing performed. HLA type, symptoms, serology pattern, and response to a gluten-free diet were analyzed using univariate logistic regression modeling, adjusted for age and gender. RESULTS: Half of the (63 (51)) LD patients lack the Class 2 HLA genotypes encoding DQ2 or DQ8 whereas only 11 (2) CD patients had neither DQ2 nor DQ8, P<0.001. The genes encoding DQ2 were much more prevalent in CD (91) than that in LD (37, P<0.001), however, the rate of carriage of DQ8 did not differ between the two groups (15 vs. 15, P0.9). Although diarrhea and weight loss were equally frequent in LD and CD patients, LD patients were less likely to be associated with anemia (P0.007), malaise (P0.006), skin disorder (P0.007), or a family history of CD (P<0.001). The LD subjects were much less likely to have tissue transglutaminase or endomysial antibodies than were CD subjects (12 or 0 vs. 87 and 87; P<0.001, respectively). CONCLUSIONS: The LD cohort differs significantly in terms of HLA type, serology, and clinical features, suggesting that the majority of patients with LD do not belong in the spectrum of CD.

UR - http://www.scopus.com/inward/record.url?scp=60749121588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60749121588&partnerID=8YFLogxK

U2 - 10.1038/ajg.2008.7

DO - 10.1038/ajg.2008.7

M3 - Article

VL - 104

SP - 142

EP - 148

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 1

ER -